How Many Doses in a Tesofensine Vial? (Dosing Guide)

Most researchers assume one vial of tesofensine equals roughly one month of treatment. But that assumption collapses the moment you account for concentration variability and dosing protocols. A 5mg lyophilised vial reconstituted with 2mL bacteriostatic water and dosed at 0.25mg per administration yields 20 doses. Change any one variable. Concentration, reconstitution volume, or target dose. And the math shifts entirely. We've worked with research teams who've run short mid-protocol because they calculated doses based on manufacturer labeling alone without accounting for actual reconstituted concentration.

How many doses are in a tesofensine vial?

A tesofensine vial typically contains 10–30 doses depending on three factors: the lyophilised peptide mass (commonly 2mg, 5mg, or 10mg), the volume of bacteriostatic water used for reconstitution (1–5mL), and the target dose per administration (0.125mg–1.0mg). For example, a 5mg vial reconstituted with 2mL yields a concentration of 2.5mg/mL. At a 0.25mg dose, that's 20 administrations. At 0.5mg per dose, the same vial yields 10 administrations.

Here's what most dosing guides won't tell you: the single biggest mistake isn't miscounting doses. It's failing to account for the 'dead volume' trapped in the vial and syringe after each draw. Even with precise measurement, approximately 0.05–0.1mL per draw is lost to syringe retention and vial residue. Over 15–20 draws, that compounds into one full missed dose.

Tesofensine Vial Concentrations and Dose Yield

Tesofensine vials are supplied as lyophilised powder in fixed peptide masses. Typically 2mg, 5mg, or 10mg per vial. The concentration you achieve after reconstitution determines how many individual doses that vial contains. Standard reconstitution uses bacteriostatic water at volumes ranging from 1mL to 5mL depending on the desired final concentration and the precision of your dosing equipment.

A 5mg vial reconstituted with 2mL bacteriostatic water produces a 2.5mg/mL solution. If your protocol calls for 0.25mg per dose, each administration requires 0.1mL. Yielding 20 doses from that single vial. If the protocol uses 0.5mg doses, you're drawing 0.2mL per administration, cutting the yield to 10 doses. The math is linear: total peptide mass ÷ dose per administration = number of doses.

Let's be direct: there is no universal 'doses per vial' answer. The number depends entirely on what concentration you reconstitute to and what dose your protocol specifies. A researcher using 0.125mg doses from a 10mg vial reconstituted to 5mg/mL (2mL total volume) gets 80 doses. A researcher using 1.0mg doses from the same vial gets 10 doses. Both are correct. For their protocols.

Reconstitution Math: How Volume and Concentration Determine Dose Count

Reconstitution is where most dose-counting errors originate. The formula is: concentration (mg/mL) = total peptide mass (mg) ÷ reconstitution volume (mL). Once you have concentration, calculating dose volume is straightforward: dose volume (mL) = target dose (mg) ÷ concentration (mg/mL).

Example: you receive a 5mg tesofensine vial and your protocol specifies 0.25mg per dose. You reconstitute with 2mL bacteriostatic water. Concentration = 5mg ÷ 2mL = 2.5mg/mL. Dose volume = 0.25mg ÷ 2.5mg/mL = 0.1mL per dose. Total doses = 2mL ÷ 0.1mL = 20 doses.

Change the reconstitution volume to 5mL and the concentration drops to 1mg/mL. Now the same 0.25mg dose requires 0.25mL per administration. The vial still contains the same 5mg total peptide, so you still get 20 doses, but each draw is larger. The peptide count doesn't change; the volume per dose does.

Our team has found that higher-concentration reconstitutions (smaller volumes) reduce cumulative dead volume loss across multiple draws. A 5mg vial reconstituted to 1mL yields 5mg/mL. At 0.5mg per dose, that's 10 doses of 0.1mL each. The same vial reconstituted to 5mL yields 1mg/mL. 10 doses of 0.5mL each. The first option leaves 0.05–0.1mL unusable residue; the second leaves 0.25–0.5mL. Over 10 draws, low-volume reconstitution preserves an extra half-dose worth of peptide.

Tesofensine Dosing Protocols: Dose Ranges and Administration Frequency

Tesofensine research protocols typically use doses between 0.125mg and 1.0mg per administration. Early-phase human trials explored doses as high as 2mg, but adverse event rates (tachycardia, hypertension, insomnia) at that level led most subsequent research to focus on the 0.25mg–0.5mg range. The specific dose your protocol uses determines how many administrations a single vial supports.

Standard administration frequency is once daily, though some protocols use alternate-day dosing or tiered schedules during tolerance assessment phases. A researcher following a 0.25mg daily protocol with a 5mg vial (20 doses at that concentration) has a 20-day supply. A 0.5mg daily protocol halves that to 10 days. Dose frequency and vial yield are directly linked. Calculating one without the other creates supply gaps.

Here's what matters for protocol planning: tesofensine has a half-life of approximately 60–80 hours in human plasma, meaning once-daily dosing maintains stable plasma levels without requiring multiple daily administrations. This extended half-life is why dose count per vial matters more than vial count per month. You're not dosing multiple times per day like shorter-acting compounds.

How Many Doses in a Tesofensine Vial?: Reconstitution Method Comparison

What If: Tesofensine Dosing Scenarios

What If I Reconstitute with Too Much Water — Can I Still Use the Vial?

Yes, but you'll need to adjust your dose volume upward. The total peptide mass in the vial doesn't change. Only the concentration. If you accidentally reconstituted a 5mg vial with 5mL instead of 2mL, your concentration is now 1mg/mL instead of 2.5mg/mL. A 0.25mg dose now requires 0.25mL instead of 0.1mL. The vial still contains 5mg total, so you still get the same number of doses. Each draw is just larger. The only practical limitation is syringe capacity: if your intended dose requires more volume than your syringe holds, you'll need a larger syringe.

What If I Lose Track of How Many Doses I've Drawn from a Vial?

Mark the vial with the reconstitution date and track draws manually. Without a log, estimating remaining doses by visual inspection is unreliable. Peptide solutions are clear and volume changes are subtle. If you've lost count, calculate backward: measure the remaining liquid volume in the vial (using a fresh syringe to draw and measure), then divide by your dose volume to estimate remaining doses. For a 2mL reconstitution with 0.1mL doses, if 1.2mL remains, you have approximately 12 doses left.

What If the Vial Contains Less Liquid Than Expected After Reconstitution?

Some peptide powder occupies physical volume even after dissolution, reducing the total liquid volume slightly below the added bacteriostatic water volume. This is normal. A 5mg vial reconstituted with 2mL water may yield 1.9–1.95mL total liquid volume because the lyophilised powder displaces a small amount of space. This doesn't affect your dose count. The peptide mass is still 5mg, so the concentration calculation remains valid.

The Unvarnished Truth About Tesofensine Vial Dosing

Here's the honest answer: most suppliers label vials by peptide mass (2mg, 5mg, 10mg), not by dose count, because dose count depends entirely on your protocol. A '5mg vial' doesn't inherently contain 10 doses or 20 doses. It contains 5mg of peptide, and how you reconstitute and dose it determines the yield. Researchers who assume 'one vial per month' without doing the math frequently run short mid-protocol or overstock unnecessarily. The calculation isn't optional. It's the only way to know your actual supply duration. Generic dosing charts from manufacturers assume standard protocols; if your protocol differs, those charts are irrelevant.

Storage and Stability: How Long Reconstituted Tesofensine Remains Viable

Once reconstituted with bacteriostatic water, tesofensine must be refrigerated at 2–8°C and used within 28 days. Beyond that window, peptide degradation accelerates. Not from bacterial contamination (bacteriostatic water contains benzyl alcohol as a preservative), but from oxidative and hydrolytic breakdown of the peptide structure itself. Unreconstituted lyophilised tesofensine stored at −20°C remains stable for 12–24 months.

Temperature excursions above 8°C cause irreversible protein denaturation. If a reconstituted vial sits at room temperature for more than 4–6 hours, potency loss begins. You can't detect this visually. The solution remains clear. But the active peptide concentration drops. This is why calculating your dose count matters: if your 20-dose vial will take 25 days to finish at your protocol's frequency, you're outside the 28-day stability window by day 29. You'll need overlapping vials or an adjusted reconstitution schedule.

We mean this sincerely: stability limits are the constraint most researchers overlook when calculating vial needs. A 10mg vial reconstituted to yield 40 doses sounds efficient. Until you realise 40 doses at once-daily frequency is 40 days, well past the 28-day bacteriostatic water stability limit. Split that 10mg across two 5mg vials reconstituted separately, and you stay within the stability window.

Calculating how many doses are in a tesofensine vial isn't a one-time setup task. It's a protocol design decision that directly affects supply continuity and peptide stability. The math is simple: peptide mass ÷ target dose = total doses. The variables. Reconstitution volume, dose frequency, stability windows, dead volume losses. Require deliberate planning. Overlook any one factor and you're either overstocked with expired peptide or scrambling mid-protocol for emergency resupply. Real Peptides provides high-purity tesofensine with exact amino-acid sequencing and batch consistency. When your dose count depends on precise concentration, source reliability isn't optional.

FAQs

[
{
"question": "How many doses are in a 5mg tesofensine vial?",
"answer": "A 5mg tesofensine vial yields 10–20 doses depending on your target dose per administration. At 0.25mg per dose, you get 20 doses; at 0.5mg per dose, you get 10 doses. The peptide mass is fixed at 5mg. The dose count varies based on how much you administer each time. Reconstitution volume affects concentration but not total dose count."
},
{
"question": "What is the correct way to calculate tesofensine dose volume?",
"answer": "First, calculate concentration: divide total peptide mass (mg) by reconstitution volume (mL). Then divide your target dose (mg) by that concentration (mg/mL) to get dose volume (mL). Example: 5mg vial reconstituted with 2mL = 2.5mg/mL concentration. A 0.25mg dose requires 0.25 ÷ 2.5 = 0.1mL per administration."
},
{
"question": "How long does reconstituted tesofensine remain stable?",
"answer": "Reconstituted tesofensine stored at 2–8°C remains stable for 28 days when mixed with bacteriostatic water. Beyond 28 days, peptide degradation accelerates even under refrigeration. Unreconstituted lyophilised powder stored at −20°C retains potency for 12–24 months. Temperature excursions above 8°C cause irreversible denaturation. Stability is time- and temperature-dependent."
},
{
"question": "Can I use a tesofensine vial beyond the 28-day reconstitution window?",
"answer": "Technically yes, but potency declines measurably after 28 days even with proper refrigeration. The bacteriostatic preservative prevents bacterial growth, but it does not prevent oxidative breakdown of the peptide chain. If your protocol requires more than 28 days of dosing from a single vial, reconstitute a smaller amount or use overlapping vials to stay within the stability window."
},
{
"question": "What happens if I reconstitute tesofensine with the wrong volume of water?",
"answer": "The total peptide mass in the vial does not change. Only the concentration. If you add more water than intended, your concentration will be lower and each dose will require a larger volume. If you add less, the concentration will be higher and dose volumes will be smaller. Recalculate your dose volume based on the actual concentration (peptide mass ÷ volume added) and adjust your syringe measurements accordingly."
},
{
"question": "How much tesofensine is lost to dead volume in the vial and syringe?",
"answer": "Approximately 0.05–0.1mL per draw is lost to syringe retention and vial residue. Over 20 draws, this compounds to 1–2mL total waste. Equivalent to one full dose lost. Low-volume reconstitutions minimise this: a 2mL reconstitution loses 5–10% to dead volume, while a 5mL reconstitution can lose 10–20%. There is no way to eliminate dead volume with standard syringes."
},
{
"question": "Is tesofensine dosed daily or weekly?",
"answer": "Tesofensine research protocols typically use once-daily dosing. The peptide has a half-life of 60–80 hours in human plasma, which supports stable levels with daily administration. Some early-phase protocols explored alternate-day dosing during tolerance assessment, but standard protocols maintain daily frequency. Weekly dosing is not supported by the pharmacokinetic profile."
},
{
"question": "What is the difference between a 2mg, 5mg, and 10mg tesofensine vial?",
"answer": "The only difference is the total peptide mass in the vial. 2mg, 5mg, or 10mg of lyophilised tesofensine powder. The peptide itself is identical across all vial sizes. Larger vials contain more total peptide and yield more doses, but the concentration you achieve depends on how much bacteriostatic water you add during reconstitution. A 10mg vial does not inherently have higher potency than a 2mg vial. It simply contains five times the peptide mass."
},
{
"question": "Can I store tesofensine at room temperature after reconstitution?",
"answer": "No. Reconstituted tesofensine must be refrigerated at 2–8°C immediately after mixing. Leaving it at room temperature for more than 4–6 hours initiates peptide degradation that cannot be reversed. Unreconstituted lyophilised powder can tolerate brief ambient temperature exposure (24–48 hours), but once mixed with bacteriostatic water, refrigeration is mandatory."
},
{
"question": "How do I know if my tesofensine vial is still potent after storage?",
"answer": "Visual inspection is unreliable. Degraded peptide solutions remain clear and show no visible change. Potency can only be verified through HPLC or mass spectrometry analysis, which is not practical for individual researchers. The only reliable safeguard is adhering to storage conditions (2–8°C for reconstituted, −20°C for lyophilised) and the 28-day post-reconstitution stability window. If storage conditions were violated, assume potency loss."
}
]
}